The Al Jalila Foundation, a member of the Mohammed Bin Rashid Al Maktoum Global Initiatives, will establish the UAE’s first robotic biobank for advanced medical research.
The facility is being launched in partnership with the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the Dubai Health Authority (DHA).
This will advance research in areas of genetic disorders, cancer, other chronic diseases, and pandemics at the world’s largest sample testing facility at the Mohammed Bin Rashid Medical Research Institute, part of Al Jalila Foundation, in Dubai Healthcare City.
RELATED STORY: New UAE initiative eases access to medical services for blind, deaf
Sheikh Ahmed bin Saeed Al Maktoum, Chairperson of Al Jalila Foundation Board of Trustees, said the launch of the UAE’s first robotic biobank reflects Dubai’s commitment to strengthen the capabilities in the healthcare sector.
The biobank will serve as an indispensable resource for the new Hamdan Bin Rashid Cancer Charity Hospital and other healthcare facilities in the UAE.
Biological samples, such as blood, tissue, cells, or body fluids will be stored at the facility besides the data on bio-molecular resources.
